Related Experiment Video
Updated: May 8, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
Distal myopathies
1Département de neurologie, centre de référence des maladies neuromusculaires, centre hospitalier et universitaire d'Angers, 4, rue Larrey, 49933 Angers cedex 9, France.
Abstract:
The distal myopathies are a heterogeneous group of genetic disorders defined by a predominant distal weakness at onset or throughout the evolution of the disease and by pathological data supporting a myopathic process. The number of genes associated with distal myopathies continues to increase. Fourteen distinct distal myopathies are currently defined by their gene and causative mutations, compared to just five entities delineated on clinical grounds two decades ago. The known proteins affected in the distal myopathies are of many types and include a significant number of sarcomeric proteins. The useful indicators for clinicians to direct towards a correct molecular diagnosis are the mode of inheritance, the age at onset, the pattern of muscle involvement, the serum creatine kinase level and the muscle pathology findings. This review gives an overview of the clinical and genetic characteristics of the currently identified distal myopathies with emphasis on some recent findings.
Insights
Distal myopathies are genetic muscle disorders affecting muscles of the limbs. Recent advances identify fourteen distinct types, aiding clinicians in diagnosing these rare diseases.
Area of Science:
- Neurology
- Genetics
- Molecular Biology
Background:
- Distal myopathies are a diverse group of genetic neuromuscular disorders.
- Characterized by weakness primarily in distal muscles.
- Pathological findings confirm a myopathic process.
Purpose of the Study:
- To review the clinical and genetic characteristics of identified distal myopathies.
- To highlight recent findings in the field.
- To provide clinicians with an overview for molecular diagnosis.
Main Methods:
- Literature review of clinical and genetic data.
- Analysis of identified genes and causative mutations.
- Summary of diagnostic indicators.
Main Results:
- Fourteen distinct distal myopathies are now defined by gene and mutation.
- Previously, only five entities were recognized clinically.
- Affected proteins include various types, notably sarcomeric proteins.
Conclusions:
- The genetic landscape of distal myopathies has expanded significantly.
- Clinical indicators like inheritance, onset, muscle pattern, CK levels, and pathology guide diagnosis.
- This review synthesizes current knowledge for improved understanding and diagnosis.
More Related Videos
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis ll: Pathophysiology
Alterations in Muscle Tone lll
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...

